Understanding how mycobacterial proteins transport lipids and drugs
Intermembrane transport of lipids and metabolites by mycobacterial MmpL protein complexes
This study is looking at how certain bacteria, like the one that causes tuberculosis, move fats and medicines around, which is important for finding new ways to treat tough infections that don't respond to regular drugs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project ID | NIH-11022509 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which Mycobacterium tuberculosis and related bacteria transport lipids and drugs, which is crucial for developing new treatments against multidrug-resistant infections. The focus is on specific protein complexes known as MmpL transporters, which play a significant role in these processes. By studying the structure and function of these transporters, researchers aim to uncover new insights that could lead to the discovery of effective therapeutics. The project employs advanced techniques such as cryo-electron microscopy to visualize these proteins and their interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by multidrug-resistant Mycobacterium species.
Not a fit: Patients with infections caused by non-mycobacterial pathogens or those who are not resistant to standard antibiotic treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that are effective against drug-resistant mycobacterial infections.
How similar studies have performed: Previous research has shown promise in targeting similar transport mechanisms in other bacterial pathogens, indicating potential for success in this novel approach.
Where this research is happening
Norman, United States
- University of Oklahoma — Norman, United States (Active)
Researchers
- Principal investigator: Zgurskaya, Helen I — University of Oklahoma
- Study coordinator: Zgurskaya, Helen I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.